Amgen stock price
AMGN
#67

277,31 €
  

0.08%

Amgen Info

Marktkapitalisierung
149,75B €

0.08%

Tagesvolumen
67,66K €
Asset-Typ
Aktien
Angestellte
28000
Gegründet
Apr 8, 1980
Hauptbörse
Nasdaq
Branche
Biological Products, (No Diagnostic Substances)
CIK-Nummer
0000318154

Daten zu tokenisierten Aktien

Durchschn. tokenisierter Preis
280,07 €
Preisunterschied
+2,76 €(+1.00%)
Tokenisierte Marktkap.
20,68K €

0.49%

Tokenisiertes Volumen (24h)
708K €

0.6%

Emittent
Verträge
Explorer
Konverter von AMGN zu USD
AMGN
EUR
Preis-Performance
Niedrig
275,42 €
Hoch
282,43 €

Daten werden geladen

Bitte warte einen Moment, wir laden die Tabellendaten

Amgen-Community

skeleton-white
 
 
 
 
 
 

About Amgen

What is Amgen?

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Kurs Live

The current price of Amgen in the market is 277,31 €, with a 24-hour trading volume of 67,66K €. The asset's market cap is 149,75B €, after moving 0.08% in the last day.

Tokenized Amgen is trading at 280,07 €, with a tokenized market cap of 20,68K € and a 24-hour trading volume of 708K €. The tokenized asset has moved -0.50% in the past 24 hours.